Study wrapper · #864
Partially reversible bilateral non-arteritic anterior ischemic optic neuropathy and branch retinal artery occlusion following semaglutide use. a case report.
Alsakran WA, Alkhaldi HM, Magliyah MS BMC ophthalmology. 2026.
DOI: 10.1186/s12886-026-05122-yPubMed: 42432542
Editor's note
A single case report describing bilateral non-arteritic anterior ischemic optic neuropathy with branch retinal artery occlusion emerging after eleven months of semaglutide and partly recovering after discontinuation. It adds to an active safety conversation about GLP-1 agonists and NA-AION, and the temporal dechallenge pattern is suggestive, but one patient cannot establish causation. A relevant safety data point that belongs alongside the larger pharmacovigilance signal rather than standing on its own.
Plain-language abstract
In one man, vision loss from optic-nerve and retinal-artery problems appeared after 11 months on semaglutide and partly recovered once the drug was stopped.
Related coverage
Mixed
Hunger pain and its reduction; qualitative insight from people with schizophrenia on semaglutide.
International journal of qualitative studies on health and well-beingn=——2026
Weak / none
Design, synthesis, and stability evaluation of semaglutide-derived lactam-stapled peptide scaffolds for GLP-1R targeting.
Journal of enzyme inhibition and medicinal chemistryn=——2026
Mixed
Comparison of lifestyle, surgery, and semaglutide for weight management in endometrial cancer: a prospective observational study.
Journal of obstetrics and gynaecologyn=——2026